tirzepatide and spironolactone For a 50-year-old female with obesity, type 2 diabetes, hypertension who is currently taking (Mounjaro) 12.5 mg weekly, phentermine 37.5 mg daily, losartan 50 mg, and 50 mg, is Spironolactone Oral Suspension: Package Insert

She believes non-traditional healthcare players and manufacturers of vitamins and supplements will try to seize the opportunity too

Expectations point to the early 2030s for semaglutide and the early-to-mid 2030s for tirzepatide

Providers should: Ask for sourcing documentation Work with transparent, licensed compounding partners Ensure theyre using the compound for specific, documented patient needs How to Prescribe Compounded Semaglutide Providers can write a prescription for compounded semaglutide including: Dose (Sublingual) 0.07mg daily for 1 week, then titrate to the desired dose

Keep your injection schedule consistent